Sonic Healthcare Limited

Loading quotes...

Forecast

The analysts' average price target is €26.91 (+131.98%). The median is €26.91 (+131.98%).

Buy	1
Hold	0
Sell	0

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Sonic Healthcare Limited has already paid €0.67 in dividends. The last payout was in September.

Financials

In the last quarter, Sonic Healthcare Limited had revenue of €3.4bn and net profit of €212.39m

(EUR)	June 2026	YoY
Revenue	3.4bn	-
Gross profit	992.6m	-
Net profit	212.39m	-
EBITDA	658.66m	-

Fundamentals

Metric	Value
Market capitalization	€5.79bn
Number of shares	491.29m
52-week high/low	€15.61 - €11.23
Dividend yield	5.77%
Dividends TTM	€0.67
Beta	0.59
P/E ratio	15.36
PEG ratio	1.03
P/B ratio	1.12
P/S ratio	0.85

Company profile

Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners. The company operates in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.